Skip to main content
. 2018 Mar 1;13:11. doi: 10.1186/s13024-018-0244-x

Fig. 5.

Fig. 5

Treatment with PLX3397 reduces the level of fibrillar amyloid in the total brain lysates and pre-fibrillar oligomers in the blood plasma of 5XFAD mice. a An equal amount (6 μg) of total lysate from the cortex (cx) or hippocampus (hp) of each group of mice (male and female) were spotted on the membrane and incubated with antibodies specifically detecting pre-fibrillar oligomers (mA11) or fibrillar aggregates (mOC). 5 μM of oligomerized for 3 days Aβ42 was spotted as a control for antibodies to confirm the ability of the antibodies to distinguish between oligomeric vs. fibrillar conformation. Additionally, 5/10 μg of rabbit IgG were spotted as a positive control for the secondary anti-rabbit antibody. b The dot blot analyses were quantified for the mOC23 and mOC78. Whereas wild-type brains were free of amyloid, the fibrillar soluble amyloid was increased in the cortex and hippocampal lysates. However, long-term treatment with PLX3397 (290 mg/kg) decreased significantly the amount of soluble fibrillar mOC23 amyloid in the cortex (p < 0.004 with Tukey test, denoted by **) and in the hippocampus (p < 0.05 with Tukey test, denoted by *) and soluble fibrillar mOC78 amyloid in the cortex (p < 0.0018 with Tukey test, denoted by **) and in the hippocampus (p < 0.0012, denoted by **) when compared with the control-chow treated 5XFAD mice. c An equal amount of blood plasma (1 μg) of each group (male and female) was spotted on the membrane and incubated as in (a). Neither the antibodies against fibrillar mOC23, mOC78 nor mA11–118 against pre-prefibrillar oligomers detected a soluble amyloid in blood plasma. However, antibody mA11–204 has detected pre-fibrillar amyloid in the blood plasma of analyzed cohorts. d Quantification of the dot blot for mA11–204 presence in blood plasma. Some endogenous pre-fibrillar amyloid was detected in the wild-type animals, however, the amount of mA11–204-positive amyloid increased significantly in the plasma of 5XFAD animals (p < 0.0011 with Tukey test, denoted by **). Long-term administration of PLX3397 in young 5XFAD decreased the amount of pre-fibrillar oligomers (mA11–204) in blood plasma (p < 0.00082 with Tukey test, denoted by ***). A-D each assay was performed once for each individual animal due to non-significant inter-assay variability